1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 32457362 | Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways. | 2020 Aug | 2 |